DBDS
DBDS
CTDS
CTDS
TDDS
TDDS
TFDS
TFDS
CAPSEAL®
CAPSEAL®
BIOXC
BIOXC

PHEONIQUE®

TRANSDERMAL DRUG DELIVERY SYSTEM (TDDS)

NANOVESICLES WITH 3% N-Acetyl L-Cysteine, 2% White Strawberry Extracts, 2% White Tomato Extracts

An innovation designed for the deepest dermal routine, featuring 100–300 nm lipid bilayer shell technology that is highly compatible with the skin’s stratum corneum. It is engineered for controlled and slow release into the dermal layer, while enhancing bioavailability and bio-efficacy, and offering high stability against light, heat, and high-shear processing.

  • ANTIOXIDATION PROTECTION
  • BRIGHTENING
  • SKIN TONE EVENNESS
  • REVITALIZING
Mode of Action

Mode of Action

 

Reduce Melanogenic Mediators

PHEONIQUE® helps reduce key melanogenic signals that trigger melanosome formation, controlling pigment initiation at the early stage.

 

Reduce Tyrosinase Activity & Oxidative Stress

PHEONIQUE® regulates melanin production by reducing tyrosinase activity and controlling oxidative stress (ROS), which are key factors involved in melanin formation.

 

Inhibit Melanosome Transfer

PHEONIQUE® helps inhibit melanosome transfer from melanocytes to keratinocytes, reducing pigment accumulation in skin cells.

Key Ingredient

Key Ingredient for skin

 

N-ACETYL L-CYSTEINE

A powerful antioxidant precursor that boosts glutathione synthesis, helping protect skin from oxidative stress and support a brighter, more even complexion.

 

WHITE STRAWBERRY EXTRACT

A botanical antioxidant active that helps protect skin from environmental stress while enhancing skin radiance and luminosity.

 

WHITE TOMATO EXTRACT

A phytonutrient-rich extract that supports antioxidant defense and balanced pigmentation for clearer, more even-looking skin.

Nanovesicle Results

Nanovesicle results

 

108nm.

AVERAGE NANOPARTICLE SIZE

 

98%

ENTRAPMENT EFFICACY

 

-46mV

Zeta-Potential

Benefit of Nano­encapsulation

Benefit of Nanoencapsulation

 

Optimized Penetration Dimension with 100 – 300 nm , each niosome is small enough to navigate the intercellular lipid pathway of the stratum corneum while remaining large enough to avoid systemic absorption, maintaining a topical-localized action. It’s enhanced deposition in the viable epidermis and upper dermis and superior bioavailability of both hydrophilic and lipophilic actives through dual-phase distribution.

INCI & Dosage

INCI, Dosage & Recommendation

 

INCI : N-Acetyl L-Cysteine, White Strawberry Extracts, White Tomato Extracts, and others (Please contact us to get more information)

 

RECOMMEND DOSAGE : 3-5%

 

CONCERN :
– Incompatible with strong acids, bases, oxidizers and reducers.
– Recommended pH range between 5.0 and 8.0 to avoid conformational changes.

PHEONIQUE®

TRANSDERMAL DRUG DELIVERY SYSTEM (TDDS)

TDDS offered the controlled release diffusion with deepest penetration to deliver encapsulated active ingredients through stratum corneum barrier functioned to target cells as Melanocyte, Keratinocyte, Basal layer, Fibroblast and Mast cells.

BIO-efficacy & in-vivo results

64% ROS levels reduction compared with the control.
20X Enhance skin penetration compared with non-encapsulated N-Acetyl Cystein
96% Satisfaction with Reduced Dark Spots
95% Satisfaction with Softer and More Hydrated Skin
92% Satisfaction with Brighter and More Radiant Skin

SIMILAR PRODUCTS